[HTML][HTML] Nanocarriers for pancreatic cancer imaging, treatments, and immunotherapies

L Liu, PG Kshirsagar, SK Gautam, M Gulati, EI Wafa… - Theranostics, 2022 - ncbi.nlm.nih.gov
Pancreatic tumors are highly desmoplastic and immunosuppressive. Delivery and
distribution of drugs within pancreatic tumors are compromised due to intrinsic physical and …

CAR T cell therapy in solid tumors: A review of current clinical trials

U Patel, J Abernathy, BN Savani, O Oluwole… - …, 2022 - Wiley Online Library
Chimeric antigen receptor (CAR) T cell therapy has made tremendous strides in the arena of
hematological malignancies with approved therapies in certain leukemias, lymphomas, and …

Target antigen attributes and their contributions to clinically approved antibody-drug conjugates (ADCs) in haematopoietic and solid cancers

B Esapa, J Jiang, A Cheung, A Chenoweth… - Cancers, 2023 - mdpi.com
Simple Summary Antibody-Drug Conjugates (ADCs) provide effective anti-cancer
treatments. ADC development requires the identification of appropriate tumour-associated …

Association of MUC16 mutation with response to immune checkpoint inhibitors in solid tumors

L Zhang, X Han, Y Shi - JAMA Network Open, 2020 - jamanetwork.com
Importance As the third most frequently mutated gene in cancers, the association
betweenMUC16mutation and response to immune checkpoint inhibitors (ICIs) in solid …

Aberrant glycosylation as immune therapeutic targets for solid tumors

Y Matsumoto, T Ju - Cancers, 2023 - mdpi.com
Simple Summary Glycosylation is one of the most pivotal post-translational modifications on
all types of biomolecules for the formation of glycoproteins, glycolipids, and glycoRNAs in a …

The evolving role of MUC16 (CA125) in the transformation of ovarian cells and the progression of neoplasia

P Giamougiannis, PL Martin-Hirsch, FL Martin - Carcinogenesis, 2021 - academic.oup.com
MUC16 (the cancer antigen CA125) is the most commonly used serum biomarker in
epithelial ovarian cancer, with increasing levels reflecting disease progression. It is a …

Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies

A Shah, S Chaudhary, I Lakshmanan, A Aithal… - NPJ Precision …, 2023 - nature.com
Aberrantly expressed onco-mucin 16 (MUC16) and its post-cleavage generated surface
tethered carboxy-terminal (MUC16-Cter) domain are strongly associated with poor …

A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer

H Zhang, M Chi, D Su, Y Xiong, H Wei, Y Yu… - Computers in Biology …, 2023 - Elsevier
As one of the most common gynecologic malignant tumors, ovarian cancer is usually
diagnosed at an advanced and incurable stage because of its early asymptomatic onset …

Combined assembloid modeling and 3D whole-organ mapping captures the microanatomy and function of the human fallopian tube

AJ Crawford, A Forjaz, J Bons, I Bhorkar, T Roy… - Science …, 2024 - science.org
The fallopian tubes play key roles in processes from pregnancy to ovarian cancer where
three-dimensional (3D) cellular and extracellular interactions are important to their …

Design strategies for electrochemical aptasensors for cancer diagnostic devices

K Malecka, E Mikuła, EE Ferapontova - Sensors, 2021 - mdpi.com
Improved outcomes for many types of cancer achieved during recent years is due, among
other factors, to the earlier detection of tumours and the greater availability of screening …